Novel Basic and Clinical Aspects of Congenital Adrenal Hyperplasia

Reviews in Endocrine and Metabolic Disorders

Volumn 2, Issue 3, 2001, Pages 289-296

  Merke, Deborah P ^a,b   Camacho, Cheri A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

21 hydroxylase; Adrenal; Androgen; CAH; Enzyme deficiency

Indexed keywords

ANTIANDROGEN;

ADRENALECTOMY; ANIMAL; CONGENITAL ADRENAL HYPERPLASIA; DISEASE MODEL; GENE THERAPY; GENETICS; HUMAN; REVIEW;

ADRENAL HYPERPLASIA, CONGENITAL; ADRENALECTOMY; ANDROGEN ANTAGONISTS; ANIMALS; DISEASE MODELS, ANIMAL; GENE THERAPY; HUMANS;

EID: 0035434597     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011520600476     Document Type: Article

References (42)

1. New MI. Diagnosis and management of congenital adrenal hyperplasia. Annu Rev Med 1998;49:311-328.
2. Lebovitz RM, Pauli RM, Laxova R. Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening. Am J Dis Child 1984;138:571-573.
3. Chrousos GP, Loriaux DL, Mann D, Cutler GB, Jr. Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associations. Horm Res 1982;16:193-200.
4. Tajima T, Ma XM, Bornstein SR, Aguilera G. Prenatal dexamethasone treatment does not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21-hydroxylase deficient mice. Endocrinology 1999;140:3354-3362.
5. Bornstein SR, Tajima T, Eisenhofer G, Haidan A, Aguilera G. Adrenomedullary function is severely impaired in 21-hydroxylase-deficient mice. Faseb J 1999;13:1185-1194.
6. Tajima T, Okada T, Ma XM, Ramsey W, Bornstein S, Aguilera G. Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochromeP450 21-hydroxylase into the adrenal gland of 21-hydroxylase-deficient mice. Gene Ther 1999;6:1898-903.
7. Grumbach MM, Shaw EB. Further studies on the treatment of congenital adrenal hyperplasia with cortisone: IV. Effect of cortisone and compound B in infants with disturbed electrolyte metabolism, Pediatrics, 1952;10:397-413. Pediatrics 1998;102: 215-221.
8. Grumbach MM, Shaw EB. Further studies on the treatment of congenital adrenal hyperplasia with cortisone: IV. Effect of cortisone and compound B in infants with disturbed electrolyte metabolism, Pediatrics, 1952;10:397-413. Pediatrics 1998;102: 215-221.
9. Cutler GB, Jr., Laue L. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1990;323:1806-1813.
10. Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB, Jr. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2000;85:1114-1120.
11. Van Wyk JJ, Gunther DF, Ritzen EM, Wedell A, Cutler GB, Migeon CJ, New MI. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1996;81:3180-3189.
12. Merke DP, Bornstein SR, Braddock D, Chrousos GP. Adrenal lymphocytic infiltration and adrenocortical tumors in a patient with 21-hydroxylase deficiency. N Engl J Med 1999;340:1121-1122.
13. Donohoue PA PK, Migeon CJ. Congenital Adrenal Hyperplasia. Seventh edn. New York: McGraw-Hill, 1995.
14. Pang S CA. Congenital adrenal hyperplasia due to 21-hydrolxylase deficiency: New born screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993;2:105-139.
15. White PC, New MI, Dupont B. Congenital adrenal hyperplasia (2). N Engl J Med 1987;316:1580-1586.
16. White PC, New MI, Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 1986;83:5111-5115.
17. Horiuchi Y, Kawaguchi H, Figueroa F, O'Huigin C, Klein J. Dating the primigenial C4-CYP21 duplication in primates. Genetics 1993;134:331-339.
18. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992;90:584-595.
19. Morel Y, Miller WL. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 1991;20:1-68.
20. Wilson RC, Wei JQ, Cheng KC, Mercado AB, New MI. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab 1995;80:1635-1640.
21. Jaaskelainen J, Levo A, Voutilainen R, Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: Good correlation in a well defined population. J Clin Endocrinol Metab 1997;82:3293-3297.
22. Haglund-Stengler B, Martin Ritzen E, Gustafsson J, Luthman H. Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 1991;88:8352-8356.
23. White PC, Chaplin DD, Weis JH, Dupont B, New MI, Seidman JG. Two steroid 21-hydroxylase genes are located in the murine S region. Nature 1984;312:465-467.
24. Shiroishi T, Sagai T, Natsuume-Sakai S, Moriwaki K. Lethal deletion of the complement component C4 and steroid 21-hydroxylase genes in the mouse H-2 class III region, caused by meiotic recombination. Proc Natl Acad Sci USA 1987;84:2819-2823.
25. Gotoh H, Sagai T, Hata J, Shiroishi T, Moriwaki K. Steroid 21-hydroxylase deficiency in mice. Endocrinology 1988;123:1923-1927.
26. Gotoh H, Kusakabe M, Shiroishi T, Moriwaki K. Survival of steroid 21-hydroxylase-deficient mice without endogenous corticosteroids after neonatal treatment and genetic rescue by transgenesis as a model system for treatment of congenital adrenal hyperplasia in humans. Endocrinology 1994;135:1470-1476.
27. Doupe AJ, Landis SC, Patterson PH. Environmental influences in the development of neural crest derivatives: Glucocorticoids, growth factors, and chromaffin cell plasticity. J Neurosci 1985;5:2119-2142.
28. Axelrod J, Reisine TD. Stress hormones: Their interaction and regulation. Science 1984;224:452-459.
29. Goodman R, Edgar D, Thoenen H, Wechsler W, Herschman H. Glucocorticoid induction of tyrosine hydroxylase in a continous cell line of rat pheochromocytoma. J Cell Biol 1978;78:R1-7.
30. Harlan RE. Regulation of neuropeptide gene expression by steroid hormones. Mol Neurobiol 1988;2:183-200.
31. Fossom LH, Sterling CR, Tank AW. Regulation of tyrosine hydroxylase gene transcription rate and tyrosine hydroxylase mRNA stability by cyclic AMP and glucocorticoid. Mol Pharmacol 1992;42:898-908.
32. Bornstein S, Bottner A, Chrousos G. Knocking out the stress response. Mol Psychiatry 1999;4:403-407.
33. White PC, New MI, Dupont B. Congenital adrenal hyperplasia (2). N Engl J Med 1987;316:1519-1524.
34. Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M, Ibanez L, Bernasconi S. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1996;81:601-606.
35. Pescovitz OH, Comite F, Hench K, Barnes K, McNemar A, Foster C, Kenigsberg D, Loriaux L, Cutler GB. The NIH experience with precocious puberty: Diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. J Pediatr 1986;108:47-54.
36. DiMartino-Nardi J, Stoner E, O'Connell A, New MI. The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH). Acta Endocrinol Suppl 1986;279:305-314.
37. Merke DP, Cutler GB, Jr. New approaches to the treatment of congenital adrenal hyperplasia. JAMA 1997;277:1073-1076.
38. Wells SA, Merke DP, Cutler GB, Jr., Norton JA, Lacroix A. Therapeutic controversy: The role of laparoscopic surgery in adrenal disease. J Clin Endocrinol Metab 1998;83:3041-3049.
39. Nasir J, Royston C, Walton C, White MC. 11 beta-hydroxylase deficiency: management of a difficult case by laparoscopic bilateral adrenalectomy. Clin Endocrinol (Oxf) 1996;45:225-228.
40. Zachmann M, Manella B, Kempken B, Knorr-Muerset G, Atares M, Prader A. Ovarian steroidogenesis in an adrenalectomized girl with 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 1984;21:575-582.
41. Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-hydroxylase deficiency: Genotype may not predict phenotype. J Clin Endocrinol Metab 1995;80:2322-2329.
42. Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 2000; 343:1362-1368.